Summary: This unblinded, pragmatic, noninferiority randomized clinical trial aimed to assess the efficacy of direct oral anticoagulants (DOACs) against low-molecular-weight heparin (LMWH) in preventing recurrent venous thromboembolism (VTE) in patients with cancer. The study included 671 patients from 67 oncology centers, with a new clinical or radiological diagnosis of VTE. Participants were randomly assigned to […]

The post RCT | Noninferiority shown between DOACs and LMWH for recurrent VTE prevention in cancer patients appeared first on Links Medicus.